228 related articles for article (PubMed ID: 12682635)
21. 1alpha,25(OH)2-vitamin D3 inhibits HGF synthesis and secretion from MG-63 human osteosarcoma cells.
Chattopadhyay N; MacLeod RJ; Tfelt-Hansen J; Brown EM
Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E219-27. PubMed ID: 12388161
[TBL] [Abstract][Full Text] [Related]
22. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
Tu Y; Gardner A; Lichtenstein A
Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt.
Schulze-Bergkamen H; Brenner D; Krueger A; Suess D; Fas SC; Frey CR; Dax A; Zink D; Büchler P; Müller M; Krammer PH
Hepatology; 2004 Mar; 39(3):645-54. PubMed ID: 14999683
[TBL] [Abstract][Full Text] [Related]
24. Preferential binding of Grb2 or phosphatidylinositol 3-kinase to the met receptor has opposite effects on HGF-induced myoblast proliferation.
Leshem Y; Gitelman I; Ponzetto C; Halevy O
Exp Cell Res; 2002 Apr; 274(2):288-98. PubMed ID: 11900489
[TBL] [Abstract][Full Text] [Related]
25. Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanism.
Dai Y; Landowski TH; Rosen ST; Dent P; Grant S
Blood; 2002 Nov; 100(9):3333-43. PubMed ID: 12384435
[TBL] [Abstract][Full Text] [Related]
26. Human myeloma cells adhere to fibronectin in response to hepatocyte growth factor.
Holt RU; Baykov V; Rø TB; Brabrand S; Waage A; Sundan A; Børset M
Haematologica; 2005 Apr; 90(4):479-88. PubMed ID: 15820943
[TBL] [Abstract][Full Text] [Related]
27. Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway.
Okano J; Shiota G; Matsumoto K; Yasui S; Kurimasa A; Hisatome I; Steinberg P; Murawaki Y
Biochem Biophys Res Commun; 2003 Sep; 309(2):298-304. PubMed ID: 12951049
[TBL] [Abstract][Full Text] [Related]
28. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.
Cacci E; Salani M; Anastasi S; Perroteau I; Poiana G; Biagioni S; Augusti-Tocco G
J Neurosci Res; 2003 Dec; 74(5):760-8. PubMed ID: 14635227
[TBL] [Abstract][Full Text] [Related]
29. Hepatocyte growth factor-induced proliferation of hepatic stem-like cells depends on activation of NF-kappaB.
Yao P; Zhan Y; Xu W; Li C; Yue P; Xu C; Hu D; Qu CK; Yang X
J Hepatol; 2004 Mar; 40(3):391-8. PubMed ID: 15123351
[TBL] [Abstract][Full Text] [Related]
30. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
[TBL] [Abstract][Full Text] [Related]
31. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
32. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase.
Fan S; Ma YX; Wang JA; Yuan RQ; Meng Q; Cao Y; Laterra JJ; Goldberg ID; Rosen EM
Oncogene; 2000 Apr; 19(18):2212-23. PubMed ID: 10822371
[TBL] [Abstract][Full Text] [Related]
33. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
34. Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor.
Taylor CC
Endocrinology; 2000 Apr; 141(4):1545-53. PubMed ID: 10746662
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts.
Kobayashi E; Sasamura H; Mifune M; Shimizu-Hirota R; Kuroda M; Hayashi M; Saruta T
Kidney Int; 2003 Oct; 64(4):1179-88. PubMed ID: 12969135
[TBL] [Abstract][Full Text] [Related]
36. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
Hu B; Guo P; Bar-Joseph I; Imanishi Y; Jarzynka MJ; Bogler O; Mikkelsen T; Hirose T; Nishikawa R; Cheng SY
Oncogene; 2007 Aug; 26(38):5577-86. PubMed ID: 17369861
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
Recio JA; Merlino G
Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
[TBL] [Abstract][Full Text] [Related]
38. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway.
Ueoka Y; Kato K; Kuriaki Y; Horiuchi S; Terao Y; Nishida J; Ueno H; Wake N
Br J Cancer; 2000 Feb; 82(4):891-9. PubMed ID: 10732763
[TBL] [Abstract][Full Text] [Related]
40. Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor.
Shima N; Stolz DB; Miyazaki M; Gohda E; Higashio K; Michalopoulos GK
J Cell Physiol; 1998 Oct; 177(1):130-6. PubMed ID: 9731753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
